Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon for Acute Hepatitis C in Injection Drug Users
NCT00194480Phase 4Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Apr 2003
- Primary completion
- Dec 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated interferon alpha in hepatitis C (HCV), sponsored by National Institute on Drug Abuse. Started Apr 2003; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00194480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194480.